stockmarketproxy
/
Search
Leaderboards
About
BIIB
Nasdaq
Watch
SEC EDGAR
BIOGEN INC.
Biological Products, (No Diagnostic Substances)
·
CAMBRIDGE, MA
·
FY end 12/31
·
CIK 875045
Overview
Financials
Compensation
Governance
Insiders
Filings
Recent SEC filings
Showing 20
View on EDGAR
4
2026-05-05
PRIMARY DOCUMENT
10-Q
2026-04-29
10-Q
8-K
2026-04-29
8-K
DEF 14A
2026-04-28
DEF 14A
DEFA14A
2026-04-28
DEFA14A
8-K
2026-04-06
8-K
4
2026-04-03
PRIMARY DOCUMENT
8-K
2026-03-31
8-K
8-K
2026-03-11
CURRENT REPORT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
4
2026-02-17
PRIMARY DOCUMENT
8-K
2026-02-11
8-K